Novonesis AS (Novonesis AS) Total Stockholders Equity : $2,045 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Total Stockholders Equity?

Novonesis AS's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2,045 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Novonesis AS's Book Value per Share for the quarter that ended in Dec. 2023 was $7.37. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Novonesis AS's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.55.

Novonesis AS Total Stockholders Equity Historical Data

The historical data trend for Novonesis AS's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Total Stockholders Equity Chart

Novonesis AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,705.81

1,836.84

1,797.14

1,970.27

2,045.12

Novonesis AS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															1,970.27	1,852.51	1,947.93	2,072.79	2,045.12

Novonesis AS (OTCPK:NVZMY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Novonesis AS's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2045.122	-	0)	/	277.317
	=	7.37

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Novonesis AS's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(464.242	+	667.174)	/	2045.122
	=	0.55

Novonesis AS Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis AS (Novonesis AS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZYM B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row

By PRNewswire • 10-03-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research • 10-19-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso • 11-06-2019

Not Just Yogurt Anymore

By PRNewswire • 10-26-2023